Charterhouse buys Cooper in first deal for latest fund

The Cooper transaction is believed to be worth in the region of €700m. Charterhouse declined to comment on its investment.

The transaction marks the first deal for Charterhouse Capital Partners X, which recently reached a first close on €1.5bn. The GP published a private placement memorandum for the vehicle and began fundraising in January with a €3bn target, having raised €1bn by the time of an interim closing in May. Charterhouse X's hard-cap stands at €3.5bn.

The GP's funds have historically had a special focus on companies in the UK and France, making investments in the €300m-4bn size bracket.

Charterhouse already inked a sizable French buyout earlier this year: in April, the firm bought a 50% stake in Comexposium, in a deal that valued the French events company at €550m.

Company
Founded in 1907 and acquired by Caravelle in 2000, Cooper manufactures and distributes over-the-counter pharmaceuticals, with a range of around 4,500 products. The company is headquartered in Melun and employs 550 people. It generates turnover of around €200m.

Advisers
Vendor – Rothschild (M&A).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France
• Buyouts
• Healthcare
• France
• Charterhouse Capital Partners